Ex parte LIN et al. - Page 2




              Appeal No. 1997-4138                                                                                         
              Application No. 08/384,681                                                                                   


                            a.      An analytical device consisting essentially of an inert, opaque plastic                
              carrier having a flat, hydrophobic surface that is non-absorbent to said antigens,                           
              antibodies, haptens and to enzymes, having a multiplicity of visually locatable discrete                     
              locations and, deposited directly on said surface within at least one of said discrete                       
              locations, a spot of an insolubilized specific first binding partner of the at least one                     
              component to be detected;                                                                                    
                            b.      a working reagent conjugate of predetermined concentration of at                       
              least about 15 micrograms per ml in liquid form comprising an enzyme coupled to a                            
              specific second binding partner of the at least one component to be detected; and                            
                            c.      an enzyme substrate in liquid form comprising a material capable of                    
              reacting with said enzyme at room temperature to form a colored precipitate detectable by                    
              the naked eye against said opaque carrier.                                                                   
                     46.    A sandwich enzyme-immunoassay process for detecting the presence in a                          
              sample from the group consisting of body fluid and the body fluid diluted 1:10 or less of at                 
              least one component to be detected selected from the group consisting of antigens,                           
              antibodies and haptens, comprising:                                                                          
                            a.      applying a drop of said sample onto one of a plurality of visually                     
              locatable, discrete locations on a flat, hydrophobic surface, that is non-absorbent to said                  
              antigens, antibodies and haptens and to enzymes, of an inert, opaque plastic carrier, said                   
              location having deposited directly thereon a spot of insolubilized specific, first binding                   
              partner of the at least one component to be detected;                                                        
                            b.      incubating said carrier for up to one-half hour to immobilize said at                  
              least one component to be detected;                                                                          
                            c.      removing unbound body fluid;                                                           
                            d.      applying onto each of said discrete locations a drop of a second fluid                 
              comprising at least 15 micrograms per ml of a conjugate of an enzyme coupled to a                            
              specific second binding partner of the component to be detected;                                             
                            e.      incubating at room temperature for up to one-half hour to immobilize                   
              said conjugate;                                                                                              


                                                            2                                                              





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  Next 

Last modified: November 3, 2007